Changeflow GovPing Healthcare Class II Recall: GEM Premier 5000 PAKs due to P...
Urgent Enforcement Amended Final

Class II Recall: GEM Premier 5000 PAKs due to PCSND Errors

Favicon for changeflow.com FDA: Device Recalls Class II
Filed March 18th, 2026
Detected March 29th, 2026
Email

Summary

The FDA has issued a Class II recall for Instrumentation Laboratory's GEM Premier 5000 PAKs (Part No. 00055407508) due to an increased incidence of Process Control Solution Not Detected (PCSND) errors. The recall is ongoing and has worldwide distribution.

What changed

The FDA has classified a recall of GEM Premier 5000 PAKs (cartridges) as Class II, indicating that the use of or exposure to a defective product may cause adverse health consequences that are reversible or temporary. The issue stems from an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, leading to GEM PAK ejection. This recall affects product part number 00055407508.

Healthcare providers using the GEM Premier 5000 system should be aware of this recall and monitor for PCSND errors. While the recall is ongoing and distribution is worldwide, specific actions for providers are not detailed in this notice. The FDA's classification suggests that while adverse events are possible, they are likely reversible or temporary, but vigilance is advised to ensure proper device function and patient safety.

What to do next

  1. Review internal procedures for monitoring GEM Premier 5000 PAK performance.
  2. Ensure staff are aware of potential PCSND errors and GEM PAK ejection issues.
  3. Consult manufacturer documentation for troubleshooting steps related to PCSND errors.

Source document (simplified)

Instrumentation Laboratory

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1529-2026 · 20260318 · Ongoing

Product

GEM Premier 5000 PAK; Part No. 00055407508.

Reason for Recall

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...

Distribution

Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...

Source: openFDA Enforcement API

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
March 18th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1529-2026

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Recalls Device Maintenance
Geographic scope
United States US

Taxonomy

Primary area
Product Safety
Operational domain
Compliance
Topics
Medical Devices Healthcare

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.